Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ronald D. Alvarez, University of Alabama at Birmingham Identifier:
First received: June 11, 2009
Last updated: February 11, 2013
Last verified: February 2013